QSI
Quantum-Si Inc
NASDAQ · Life Sciences Tools & Services
$1.07
+0.13 (+14.26%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 103.67M | 96.64M | 82.78M |
| Net Income | 19.40M | 17.32M | 13.90M |
| EPS | — | — | — |
| Profit Margin | 18.7% | 17.9% | 16.8% |
| Rev Growth | +24.5% | +20.4% | +4.7% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 76.33M | 95.82M | 94.79M |
| Total Equity | 101.80M | 98.79M | 108.25M |
| D/E Ratio | 0.75 | 0.97 | 0.88 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 28.41M | 27.92M | 24.82M |
| Free Cash Flow | 15.60M | 15.72M | 10.37M |